| For: | Chen C, Fichna J, Laudon M, Storr M. Antinociceptive effects of novel melatonin receptor agonists in mouse models of abdominal pain. World J Gastroenterol 2014; 20(5): 1298-1304 [PMID: 24574803 DOI: 10.3748/wjg.v20.i5.1298] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i5/1298.htm |
| Number | Citing Articles |
| 1 |
Natasha Ivanova, Zlatina Nenchovska, Milena Atanasova, Moshe Laudon, Rumyana Mitreva, Jana Tchekalarova. Chronic Piromelatine Treatment Alleviates Anxiety, Depressive Responses and Abnormal Hypothalamic–Pituitary–Adrenal Axis Activity in Prenatally Stressed Male and Female Rats. Cellular and Molecular Neurobiology 2022; 42(7) doi: 10.1007/s10571-021-01100-8
|
| 2 |
Adam Gędek, Szymon Modrzejewski, Michał Materna, Zofia Szular, Adam Wichniak, Paweł Mierzejewski, Monika Dominiak. Efficacy and Safety of Agomelatine in Depressed Patients with Diabetes: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences 2024; 25(23) doi: 10.3390/ijms252312631
|
| 3 |
Taliha H. Aydın, Özgür D. Can, Ümide Demir Özkay, Nazlı Turan. Effect of subacute agomelatine treatment on painful diabetic neuropathy: involvement of catecholaminergic mechanisms. Fundamental & Clinical Pharmacology 2016; 30(6) doi: 10.1111/fcp.12224
|
| 4 |
Serafina Perrone, Laura Cannavò, Sofia Gerevini, Luca Buttarelli, Pietro Leuratti, Elisa Caselli, Chiara Petrolini, Vincenzo Raitano, Virginia Beretta, Silvia Carloni. From Oxidative Stress to Pain Modulation With Melatonin in Neonatal and Pediatric Care. Clinical Therapeutics 2026; 48(7) doi: 10.1016/j.clinthera.2026.04.017
|
| 5 |
Ricássio S. Barberino, Vanúzia G. Menezes, Anita E. A. S. Ribeiro, Raimundo C. Palheta Jr, Xuejun Jiang, Johan E. J. Smitz, Maria Helena T. Matos. Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity†. Biology of Reproduction 2017; 96(6) doi: 10.1093/biolre/iox053
|
| 6 |
Zhuo-Ying Tao, Richard J. Traub, Dong-Yuan Cao. Epigenetics of Chronic Pain. 2019; doi: 10.1016/B978-0-12-814070-3.00008-9
|
| 7 |
Anthony C. Johnson, Beverley Greenwood-Van Meerveld. Gastrointestinal Pharmacology. Handbook of Experimental Pharmacology 2017; 239 doi: 10.1007/164_2016_120
|
| 8 |
M Salaga, P R Polepally, M Zielinska, M Marynowski, A Fabisiak, N Murawska, K Sobczak, M Sacharczuk, J C Do Rego, B L Roth, J K Zjawiony, J Fichna. Salvinorin A analogues PR‐37 and PR‐38 attenuate compound 48/80‐induced itch responses in mice. British Journal of Pharmacology 2015; 172(17) doi: 10.1111/bph.13212
|
| 9 |
Merve Kasap, Özgür Devrim Can. Opioid system mediated anti-nociceptive effect of agomelatine in mice. Life Sciences 2016; 163 doi: 10.1016/j.lfs.2016.08.031
|
| 10 |
Atousa Moghadam Fard, Pardis Goodarzi, Mehran Mottahedi, Setareh Garousi, Hamed Zadabhari, Mohammad Kalantari Shahijan, Saeedeh Esmaeili, Mohsen Nabi-Afjadi, Bahman Yousefi. Therapeutic applications of melatonin in disorders related to the gastrointestinal tract and control of appetite. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(8) doi: 10.1007/s00210-024-02972-5
|
| 11 |
Michael T. Li, Christopher Louis Robinson, Qing Zhao Ruan, Sindhuja Surapaneni, Warren Southerland. The Influence of Sleep Disturbance on Chronic Pain. Current Pain and Headache Reports 2022; 26(10) doi: 10.1007/s11916-022-01074-2
|
| 12 |
Sara Di Girolamo, Giulia Terribile, Paola Alberti, Guido Cavaletti. Sodium channel modulation as a therapeutic strategy for chemotherapy-induced peripheral neurotoxicity. Expert Opinion on Investigational Drugs 2025; 34(11) doi: 10.1080/13543784.2025.2586615
|
| 13 |
Anita Eugenia Alencar Santos Ribeiro, Eliane Feitosa Ferreira, Jaknea dos Santos Leal, Ricássio de Sousa Barberino, Helinando Pequeno de Oliveira, Raimundo Campos Palheta Junior. Involvement of MT2 receptors in protective effects of melatonin against cisplatin-induced gastrointestinal damage in mice. Brazilian Journal of Pharmaceutical Sciences 2022; 58 doi: 10.1590/s2175-97902022e20476
|
| 14 |
Beverley Greenwood-Van Meerveld, Dawn K. Prusator, Anthony C. Johnson. Animal models of gastrointestinal and liver diseases. Animal models of visceral pain: pathophysiology, translational relevance, and challenges. American Journal of Physiology-Gastrointestinal and Liver Physiology 2015; 308(11) doi: 10.1152/ajpgi.00463.2014
|
| 15 |
Jun Zhou, Jin Zhang, XiaoHong Luo, MaoXing Li, Ying Yue, Moshe Laudon, ZhengPing Jia, RuXue Zhang. Neu-P11, a novel MT1/MT2 agonist, reverses diabetes by suppressing the hypothalamic-pituitary-adrenal axis in rats. European Journal of Pharmacology 2017; 812 doi: 10.1016/j.ejphar.2017.07.001
|
| 16 |
Richard J. Bodnar. Endogenous opiates and behavior: 2014. Peptides 2016; 75 doi: 10.1016/j.peptides.2015.10.009
|
| 17 |
Paula Mosińska, Katarzyna Socała, Dorota Nieoczym, Moshe Laudon, Martin Storr, Jakub Fichna, Piotr Wlaź. Anticonvulsant activity of melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, in mice. Behavioural Brain Research 2016; 307 doi: 10.1016/j.bbr.2016.03.036
|